Abstract
Purpose
To examine the impact of detection biases on three prostate cancer biochemical failure (bF) definitions in comparison with the existing American Society for Therapeutic Radiology and Oncology Consensus Definition (ACD).Methods and materials
Three alternative bF definitions were tested against the ACD: three rises in prostate-specific antigen (PSA) level without backdating, nadir plus 2 ng/mL, and a threshold PSA level of >3 ng/mL, according to data from 1050 men. The mean time between PSA tests (MTBT), regularity of collection, and calendar year of analysis were examined in each bF definition.Results
The MTBT produced a statistically significant difference in the derived hazard ratio for identification of bF in all definitions. The influence of test regularity was statistically significant beyond the median level of regularity in all definitions. The year of analysis impacted greatly on the ACD, whereas the three alternative definitions exhibited minor follow-up duration variations by comparison. The alternative definitions had reliable follow-up when the crude median time to censoring was at least 1.6 times greater than that of failure.Conclusions
Detection biases will always be a significant issue in defining bF. A number of alternative failure definitions have more predictable interactions with these biases than the existing ACD.References
Articles referenced by this article (14)
Consensus statement
Int J Radiat Oncol Biol Phys 1997
Definitions of biochemical failure in prostate cancer following radiation therapy.
Int J Radiat Oncol Biol Phys, (5):1212-1219 2001
MED: 11483331
Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer.
J Clin Oncol, (19):3352-3359 2000
MED: 11013275
A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria.
J Urol, (4 Pt 1):1419-1422 2002
MED: 12352408
The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer.
Int J Radiat Oncol Biol Phys, (3):553-561 1999
MED: 10524405
Caution in interpreting biochemical control rates after treatment of prostate cancer: length of follow-up influences results.
Urology, (5):875-879 1999
MED: 10565750
A standard definition of disease freedom is needed for prostate cancer: undetectable prostate specific antigen compared with the American Society of Therapeutic Radiology and Oncology consensus definition.
J Urol, (3):1310-1313 2002
MED: 11832720
Ambiguities within the ASTRO consensus definition of biochemical failure: never assume all is equal.
Int J Radiat Oncol Biol Phys, (4):1083-1092 2004
MED: 15001248
Evaluation of the Houston biochemical relapse definition in men treated with prolonged neoadjuvant and adjuvant androgen ablation and assessment of follow-up lead-time bias.
Int J Radiat Oncol Biol Phys, (1):11-18 2003
MED: 12909209
PSA relapse definitions--the Vancouver Rules show superior predictive power.
Int J Radiat Oncol Biol Phys, (3):699-700 1999
MED: 10078660
Show 4 more references (10 of 14)
Citations & impact
Impact metrics
Citations of article over time
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1016/j.ijrobp.2005.08.003
Article citations
Surrogate endpoints in early prostate cancer research.
Transl Androl Urol, 7(3):472-482, 01 Jun 2018
Cited by: 10 articles | PMID: 30050805 | PMCID: PMC6043744
Review Free full text in Europe PMC
The impact of the definition of biochemical recurrence following salvage radiotherapy on outcomes and prognostication in patients with recurrent prostate cancer after radical prostatectomy: a comparative study of three definitions.
Prostate Int, 7(2):47-53, 05 May 2018
Cited by: 7 articles | PMID: 31384605 | PMCID: PMC6664305
Changes of protein expression in prostate cancer having lost its androgen sensitivity.
Int Urol Nephrol, 47(7):1149-1154, 08 May 2015
Cited by: 3 articles | PMID: 25953123
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer.
Urol Oncol, 32(1):30.e1-7, 12 Feb 2013
Cited by: 3 articles | PMID: 23410946
Validating the interval to biochemical failure for the identification of potentially lethal prostate cancer.
J Clin Oncol, 30(15):1857-1863, 16 Apr 2012
Cited by: 50 articles | PMID: 22508816
Go to all (11) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Ambiguities within the ASTRO consensus definition of biochemical failure: never assume all is equal.
Int J Radiat Oncol Biol Phys, 58(4):1083-1092, 01 Mar 2004
Cited by: 11 articles | PMID: 15001248
Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer.
Int J Radiat Oncol Biol Phys, 63(5):1455-1462, 19 Sep 2005
Cited by: 34 articles | PMID: 16169682
PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time.
Int J Radiat Oncol Biol Phys, 64(2):512-517, 06 Oct 2005
Cited by: 54 articles | PMID: 16213667
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
J Urol, 177(2):540-545, 01 Feb 2007
Cited by: 482 articles | PMID: 17222629
Review